Ada Rephaeli
Petah Tiqwa, M 49100, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells.
Journal: Cancer chemotherapy and pharmacology
Published: December 06, 2021
Valproic Acid Prodrug Affects Selective Markers, Augments Doxorubicin Anticancer Activity and Attenuates Its Toxicity in a Murine Model of Aggressive Breast Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 11, 2021
A switch in mechanism of action prevents doxorubicin-mediated cardiac damage.
Journal: Biochemical pharmacology
Published: October 22, 2020
Cardioprotection by AN-7, a prodrug of the histone deacetylase inhibitor butyric acid: Selective activity in hypoxic cardiomyocytes and cardiofibroblasts.
Journal: European journal of pharmacology
Published: January 21, 2020
Conjugate prodrug AN-233 induces fetal hemoglobin expression in sickle erythroid progenitors and β-YAC transgenic mice.
Journal: Blood cells, molecules & diseases
Published: July 08, 2019
The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model.
Journal: International journal of molecular sciences
Published: January 23, 2019
Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.
Journal: Journal of cellular biochemistry
Published: July 18, 2017
AN-7, a butyric acid prodrug, sensitizes cutaneous T-cell lymphoma cell lines to doxorubicin via inhibition of DNA double strand breaks repair.
Journal: Investigational new drugs
Published: June 08, 2017
Effect of Histone Deacetylase Inhibitor, Butyroyloxymethyl-Diethyl Phosphate (AN-7), on Corneal Neovascularization in a Mouse Model.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: March 25, 2017
Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograft.
Journal: Investigational new drugs
Published: December 11, 2016
Bi-functional prodrugs of 5-aminolevulinic acid and butyric acid increase erythropoiesis in anemic mice in an erythropoietin-independent manner.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: March 15, 2016
The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin.
Journal: PloS one
Published: August 19, 2015
Last Updated: 09/26/2026